SPH Notice – Hartley Campbell Atkinson and Colin McKay

1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
To NZX Limited
and
To ASX Limited
and
To AFT Pharmaceuticals Limited (“AFT”)
Relevant event being disclosed: Movement of 1% or more
Date of relevant event: 15 June 2020
Date this disclosure made: 15 June 2020
Date last disclosure made: 10 June 2015
Substantial product holder(s) giving disclosure
Full name(s): Hartley Campbell Atkinson and Colin McKay as trustees of the Atkinson
Family Trust
Summary of substantial holding
Class of quoted voting products: Ordinary shares in AFT (“Shares”)
Summary for Hartley Campbell Atkinson and Colin McKay as trustees of the Atkinson
Family Trust (“AF Trust”)
For this disclosure,—
(a) total number held in class: 72,031,609
(b) total in class: 103,167,716
(c) total percentage held in class: 69.820%
For last disclosure,—
(a) total number held in class:72,964,942
(b) total in class: 100,501,049
(c) total percentage held in class: 72.601%
Details of transactions and events giving rise to relevant event
On 10 June 2020, the AF Trust, AFT and others entered into a placement and sell down
agreement (“Underwriting Agreement”) with Bell Potter Securities Limited and Forsyth
Barr Group Limited as advised in a notice dated 10 June 2020 (“Previous Notice”).
A copy of the Underwriting Agreement was attached to the Previous Notice.

2
Pursuant to the Underwriting Agreement, on 15 June 2020 the AF Trust sold 933,333
Shares at a price of $3.75 per Share, for total consideration of $3,499,998.75. In addition,
on 15 June 2020 AFT issued 2,666,667 new Shares.
As disclosed in the Previous Notice, under the Underwriting Agreement the AF Trust
agreed, for a period of three months after the settlement date of the Offer (as defined in
the Previous Notice and such date being 15 June 2020) to not sell or transfer any Shares
or otherwise grant any person an option or right to acquire any Shares held by it, except in
the circumstances described in the Underwriting Agreement. The remaining 72,031,609
Shares held by the AF Trust remain subject to this restriction.
Details after relevant event
Details for Hartley Campbell Atkinson and Colin McKay as trustees of the AF Trust
Nature of relevant interest(s): Hartley Campbell Atkinson and Colin McKay, as trustees of
the AF Trust are the registered holders of 72,964,942 Shares that are subject to the events
described in this notice.
For that relevant interest,—
(a) number held in class: 72,031,609
(b) percentage held in class: 69.820%
(c) current registered holder(s): Unchanged
(d) registered holder(s) once transfers are registered: Hartley Campbell Atkinson and
Colin McKay as trustees of the AF Trust as to 72,031,609 Shares and unknown as to
the 933,333 transferred Shares
Additional information
Address(es) of substantial product holder(s): Level 1, 129 Hurstmere Road, Takapuna
Auckland 0622
Contact details (Hartley Atkinson):
Tel: 09 488 0232
hartley@aftpharm.com

Contact details (Colin McKay):
Tel: +4 9 520 4544
colinmckay@wilsonmckay.co.nz

Disclosure has effect for purposes of directors’ and senior managers’ disclosure
Hartley Campbell Atkinson is also a director of AFT. This disclosure also constitutes
disclosure for the purposes of the directors’ and senior managers’ disclosure obligations.

3
Certification
I, Hartley Campbell Atkinson as trustee of the Atkinson Family Trust, certify that, to the
best of my knowledge and belief, the information contained in this disclosure is correct and
that I am duly authorised to make this disclosure by all persons for whom it is made.